Please login to the form below

Not currently logged in
Email:
Password:

Merck KGaA appoints new chief information officer

Promotes the head of its strategy realisation office James Stewart

Merck KGaA James StewartJames Stewart has been appointed chief information officer at Merck KGaA to replace Frédéric Wohlwend on October 1, 2013.

The appointment is a promotion for Stewart who is current head of the strategy realisation office at Merck KGaA's pharma division Merck Serono.

His new position will see him take on a wider set of responsibilities, leading the entire Merck KGaA group's efforts in information technology.

“We thank Frédéric Wohlwend for his many years of service to our company in various leadership positions and we regret his decision to leave Merck,” said executive board member Kai Beckmann of the previous chief information officer who leaves after just two years in his last role company.

Beckmann added: “However, we are pleased to have appointed James Stewart, a highly qualified and experienced manager, to succeed him.”

Stewart's experience in the pharma industry includes more than 20 years at US pharma company Merck & Co, which he joined in 1984 in human resources.

During his time at Merck & Co, he worked his way up the ranks, moving to Europe in 2001 to take on the role of executive director and international chief information for EMEA, Canada, Latin America and Asia- Pacific.

In 2009, he was appointed VP and programme realisations officer within in the emerging markets business unit of Merck & Co before leaving to join Merck Serono in 2011.

2nd September 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....

Infographics